NEW YORK – Yourgene Health said on Tuesday that it has partnered with international payments firm Caxton and immunity passport app provider Hooha Innovations to provide back-to-work molecular COVID-19 testing for businesses in the UK.
Under the collaboration, Caxton will offer COVID-19 tests to its network of corporate clients and their employees, who can request a test using Hooha's immunity passport app Prova. Yourgene will provide sample collection kits, train healthcare professionals to take samples, and conduct the testing in its Manchester laboratory using its CE-marked, PCR-based Clarigene SARS-CoV-2 assay. Individuals will obtain their test results through the Prova app, which allows them to share them without revealing any personal information.
Yourgene said it is still on track to release a research-use-only version of the Clarigene test by the end of June and to obtain CE marking for an in vitro diagnostic kit version in July, as announced in May.
"We are proud to support this effort as the COVID-19 lab partner to this collaboration, working with Caxton and Prova, enabling employees to return to work safely," said Yourgene CEO Lyn Rees in a statement. "We look forward to updating the market as the project progresses as we expect to launch in summer 2020."